D'AMELIO, MARCELLO
 Distribuzione geografica
Continente #
AS - Asia 4.790
NA - Nord America 1.822
EU - Europa 821
SA - Sud America 131
Continente sconosciuto - Info sul continente non disponibili 60
AF - Africa 39
OC - Oceania 9
Totale 7.672
Nazione #
SG - Singapore 3.606
US - Stati Uniti d'America 1.754
CN - Cina 590
IT - Italia 381
HK - Hong Kong 339
GB - Regno Unito 152
FR - Francia 109
BR - Brasile 90
IN - India 61
VN - Vietnam 51
DE - Germania 45
CA - Canada 37
NL - Olanda 28
BD - Bangladesh 24
ZA - Sudafrica 20
TR - Turchia 18
MX - Messico 16
FI - Finlandia 14
ES - Italia 13
LU - Lussemburgo 13
AR - Argentina 12
CO - Colombia 12
JP - Giappone 12
ID - Indonesia 10
IQ - Iraq 10
UA - Ucraina 10
AU - Australia 9
RU - Federazione Russa 9
SA - Arabia Saudita 9
EC - Ecuador 8
JO - Giordania 8
PL - Polonia 8
PH - Filippine 7
PK - Pakistan 7
LT - Lituania 6
MA - Marocco 6
SE - Svezia 6
UZ - Uzbekistan 6
TW - Taiwan 5
AL - Albania 4
IR - Iran 4
MD - Moldavia 4
OM - Oman 4
TN - Tunisia 4
AT - Austria 3
CR - Costa Rica 3
DZ - Algeria 3
HU - Ungheria 3
JM - Giamaica 3
KR - Corea 3
PE - Perù 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
BG - Bulgaria 2
EE - Estonia 2
EG - Egitto 2
GR - Grecia 2
HT - Haiti 2
LV - Lettonia 2
MK - Macedonia 2
MY - Malesia 2
NP - Nepal 2
PT - Portogallo 2
TH - Thailandia 2
VE - Venezuela 2
XK - ???statistics.table.value.countryCode.XK??? 2
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BZ - Belize 1
CL - Cile 1
CW - ???statistics.table.value.countryCode.CW??? 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
GD - Grenada 1
HN - Honduras 1
IE - Irlanda 1
IL - Israele 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LC - Santa Lucia 1
LK - Sri Lanka 1
PS - Palestinian Territory 1
PY - Paraguay 1
RW - Ruanda 1
SN - Senegal 1
UY - Uruguay 1
Totale 7.615
Città #
San Jose 692
Ashburn 426
Singapore 421
Hong Kong 337
Rome 285
Hefei 203
London 131
Boardman 129
Beijing 127
Lauterbourg 91
Shanghai 72
Dallas 41
Council Bluffs 39
Los Angeles 34
Santa Clara 34
Milan 28
New York 25
San Francisco 23
Pune 19
Seattle 16
Chennai 15
Hanoi 13
Amsterdam 12
Montreal 12
Munich 12
Ho Chi Minh City 11
São Paulo 11
Tokyo 11
Washington 11
Johannesburg 10
Toronto 10
Frankfurt am Main 9
Brooklyn 8
Buffalo 8
Amman 7
Atlanta 7
Dudelange 7
Phoenix 7
Suzhou 7
Chicago 6
Helsinki 6
Luxembourg 6
Mexico City 6
Orem 6
Stockholm 6
Turku 6
Bogotá 5
Charlotte 5
Huntington Beach 5
Las Vegas 5
Paris 5
Quito 5
Riyadh 5
Haikou 4
Manchester 4
Muscat 4
Naples 4
Polska 4
Qingdao 4
Sydney 4
Tashkent 4
Tirana 4
Warsaw 4
Cagliari 3
Canberra 3
Changsha 3
Curitiba 3
Florence 3
Hangzhou 3
Houston 3
Istanbul 3
Kingston 3
Lima 3
Montes Claros 3
Mumbai 3
New Delhi 3
Rio de Janeiro 3
Tainan 3
Xi'an 3
Yalova 3
Ankara 2
Baghdad 2
Bangkok 2
Berlin 2
Bridgetown 2
Budapest 2
Buenos Aires 2
Cairo 2
Calgary 2
Cartago 2
Catania 2
Caxias do Sul 2
Central 2
Cleveland 2
Contagem 2
Delhi 2
Denver 2
Hyderabad 2
Hưng Yên 2
Jakarta 2
Totale 3.569
Nome #
Author Correction: Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease (Nature Communications, (2019), 10, 1, (3945), 10.1038/s41467-019-11928-w) 228
Chemogenetic rectification of the inhibitory tone onto hippocampal neurons reverts autistic-like traits and normalizes local expression of estrogen receptors in the Ambra1+/- mouse model of female autism 226
Calcium handling: a strategy to fight neurodegeneration in Alzheimer’s disease 210
Cisd2: a promising new target in Alzheimer's disease† 207
Behavioral, neuromorphological, and neurobiochemical effects induced by omega-3 fatty acids following basal forebrain cholinergic depletion in aged mice 205
Apoptosome pharmacological manipulation: from current developments in the laboratory to clinical implications 204
A novel player in the p53-mediated autophagy: Sestrin2 201
Alzheimer's Disease and Sex-Dependent Alterations in the Striatum: A Lesson from a Mouse Model 199
Hippocampal epileptogenesis in autoimmune encephalitis. 196
Passive immunotherapy for N-truncated tau ameliorates the cognitive deficits in two mouse Alzheimer's disease models 185
BODIPY-Based Analogue of the TREM2-Binding Molecular Adjuvant Sulfavant A, a Chemical Tool for Imaging and Tracking Biological Systems 169
A New Transgenic Mouse Model for Studying the Neurotoxicity of Spermine Oxidase Dosage in the Response to Excitotoxic Injury. 165
Dopamine neuron degeneration in the Ventral Tegmental Area causes hippocampal hyperexcitability in experimental Alzheimer’s Disease 156
Ambra1 shapes hippocampal inhibition/excitation balance: role in neurodevelopmental disorders 121
Autophagy Inhibition Favors Survival of Rubrospinal Neurons After Spinal Cord Hemisection. 116
Persistent elevation of D-Aspartate enhances NMDA receptor-mediated responses in mouse substantia nigra pars compacta dopamine neurons. 114
Neurodevelopmental Disorders: Functional Role of Ambra1 in Autism and Schizophrenia. 113
AMBRA1 Controls Regulatory T-Cell Differentiation and Homeostasis Upstream of the FOXO3-FOXP3 Axis. 110
Age-Related Changes of Hippocampal Synaptic Plasticity in AβPP-Null Mice are Restored by NGF through p75NTR 109
Apoptosome: An Up-and-coming Therapeutical Tool 109
The VTA dopaminergic system as diagnostic and therapeutical target for Alzheimer's disease 108
Age-dependent roles of peroxisomes in the hippocampus of a transgenic mouse model of Alzheimer's disease 104
Dopamine loss alters the hippocampus-nucleus accumbens synaptic transmission in the Tg2576 mouse model of Alzheimer's disease 102
Aβ toxicity in Alzheimer's disease 101
Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease 100
Astrocyte-Dependent Vulnerability to Excitotoxicity in Spermine Oxidase-Overexpressing Mouse 99
Acute focal brain damage alters mitochondrial dynamics and autophagy in axotomized neurons 96
Analysis of neuronal cell death in mammals 96
Early derailment of firing properties in CA1 pyramidal cells of the ventral hippocampus in an Alzheimer's disease mouse model 95
AUTOPHAGY ENHANCING COMPOUNDS, PEPTIDES AND PEPTIDOMIMETIC COMPOUNDS FOR USE IN THE TREATMENT OF NEURONAL DISEASES 90
Upregulation of Ca2+-binding proteins contributes to VTA dopamine neuron survival in the early phases of Alzheimer's disease in Tg2576 mice 84
Neuroprotective Role of Dietary Supplementation with Omega-3 Fatty Acids in the Presence of Basal Forebrain Cholinergic Neurons Degeneration in Aged Mice 80
Nilotinib restores memory function by preventing dopaminergic neuron degeneration in a mouse model of Alzheimer's Disease 75
The role of dopamine in NLRP3 inflammasome inhibition: Implications for neurodegenerative diseases 74
Transcranial alternating current stimulation (tACS) at gamma frequency: an up-and-coming tool to modify the progression of Alzheimer’s Disease 74
Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer's disease: Current trends and future perspectives 72
Neuronal caspase-3 signalling: not only cell death 68
Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer's disease 67
The "Janus-Faced Role" of Autophagy in Neuronal Sickness: Focus on Neurodegeneration. 63
Haploinsufficiency of PDE2A causes in mice increased exploratory behavior associated with upregulation of neural nitric oxide synthase in the striatum 62
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 61
Restoration of ER proteostasis attenuates remote apoptotic cell death after spinal cord injury by reducing autophagosome overload 58
A dual role of p53 in the control of autophagy 58
On the properties of identified dopaminergic neurons in the mouse substantia nigra and ventral tegmental area. 58
Repetitive prefrontal tDCS activates VTA dopaminergic neurons, resulting in attenuation of Alzheimer's Disease-like deficits in Tg2576 mice 53
Unifying Hypothesis of Dopamine Neuron Loss in Neurodegenerative Diseases: Focusing on Alzheimer's Disease. 52
Clarifying the role of D1 receptor signalling in Alzheimer's-related epilepsy commentary on Szabo et al. (2024) 51
Ventral Tegmental Area in Prodromal Alzheimer's Disease: Bridging the Gap between Mice and Humans. 48
Dopaminergic deficits along the spectrum of Alzheimer's disease 46
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 46
Faf1 is expressed during neurodevelopment and is involved in Apaf1-dependent caspase-3 activation in proneural cells 46
Caspase-3 in the central nervous system: beyond apoptosis. 44
Calcineurin inhibition rescues early synaptic plasticity deficits in a mouse model of Alzheimer's disease. 44
Insulin Receptor β-Subunit Haploinsufficiency Impairs Hippocampal Late-Phase LTP and Recognition Memory 44
Stimulation of autophagy by rapamycin protects neurons from remote degeneration after acute focal brain damage 43
Ventral tegmental area dysfunction affects decision-making in patients with myotonic dystrophy type-1 43
Early Biochemical and Morphological Modifications in the Brain of a Transgenic Mouse Model of Alzheimer's Disease: A Role for Peroxisomes 43
Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis 43
Neuregulin 1/ErbB signalling modulates hippocampal mGluRI-dependent LTD and object recognition memory. 43
Brain excitability and connectivity of neuronal assemblies in Alzheimer's disease: From animal models to human findings. 42
Ventral tegmental area disruption in Alzheimer's disease. 41
Targeting autophagy as a therapeutic strategy to prevent dopamine neuron loss in early stages of Alzheimer disease 41
Regulation of autophagy by cytoplasmic p53 41
Key role of mitochondria in Alzheimer’s Disease synaptic dysfunction 41
Functional alterations of the dopaminergic and glutamatergic systems in spontaneous α-synuclein overexpressing rats 41
Nilotinib: from animal-based studies to clinical investigation in Alzheimer's disease patients 40
Guidelines for the use and interpretation of assays for monitoring autophagy. 40
Interactions between neuroactive steroids and reelin haploinsufficiency in Purkinje cell survival 40
Emerging role of mitochondria dysfunction in the onset of neurodegenerative diseases. 40
Role of Autophagy in Brain Sculpture: Physiological and Pathological Implications 40
Matter of life and death: the pharmacological approaches targeting apoptosis in brain diseases. 39
Neuregulin 1 signalling modulates mGluR1 function in mesencephalic dopaminergic neurons 39
Nonapoptotic role for Apaf-1 in the DNA damage checkpoint 39
In vivo human molecular neuroimaging of dopaminergic vulnerability along the Alzheimer’s disease phases 39
Mutations in the TMPRSS3 gene are a rare cause of childhood nonsyndromic deafness in Caucasian patients 38
RGS9-2 rescues dopamine D2 receptor levels and signaling in DYT1 dystonia mouse models. 38
Paraoxonase gene variants are associated with autism in North America, but not in Italy: possible regional specificity in gene-environment interactions 38
Ventral tegmental area disconnection contributes two years early to correctly classify patients converted to alzheimer's disease: Implications for treatment 38
Differential expression of paralog RNA binding proteins establishes a dynamic splicing program required for normal cerebral cortex development 37
CONDITIONAL ACTIVATION OF PAX6 IN THE DEVELOPING CORTEX OF TRANSGENIC MICE CAUSES PROGENITOR APOPTOSIS 37
Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease. 37
Chronic Lithium Treatment in a Rat Model of Basal Forebrain Cholinergic Depletion: Effects on Memory Impairment and Neurodegeneration. 37
TRANSMISSION DISEQUILIBRIUM STUDY OF AN OLIGODENDROCYTE AND MYELIN GLYCOPROTEIN GENE ALLELE IN 431 FAMILIES WITH AN AUTISTIC PROBAND 36
Transient upregulation of translational efficiency in prodromal and early symptomatic Tg2576 mice contributes to Aβ pathology 36
Sam68 splicing regulation contributes to motor unit establishment in the postnatal skeletal muscle 36
Unlocking the secrets of dopamine in Alzheimer's Disease. 35
Interactions genes-environnement dans la pathogénie de l’autisme 35
Can transcranial magnetic stimulation rescue dopaminergic signalling in Alzheimer disease? 34
In vivo mapping of brainstem nuclei functional connectivity disruption in Alzheimer's disease 34
CREB is necessary for synaptic maintenance and learning-induced changes of the AMPA receptor GluA1 subunit. 34
The dynamic interaction of AMBRA1 with the dynein motor complex regulates mammalian autophagy 34
Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link? 33
Schwann cell autophagy counteracts the onset and chronification of neuropathic pain. 33
SAM68 is a physiological regulator of SMN2 splicing in spinal muscular atrophy 33
Neuroprotective effects of donepezil against cholinergic depletion. 32
Midbrain degeneration triggers astrocyte reactivity and tau pathology in experimental Alzheimer's Disease 32
Physiological and Pathological Role of Apoptosis 31
Targeting Synaptic Dysfunction and Neural Connectivity in Neurological and Psychiatric disorders 31
The role of dopaminergic midbrain in Alzheimer's disease: Translating basic science into clinical practice. 30
Pleiotropic neuropathological and biochemical alterations associated with Myo5a mutation in a rat Model. 29
Totale 7.478
Categoria #
all - tutte 52.389
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.389


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022141 0 0 3 1 0 2 1 11 4 5 3 111
2022/202389 3 0 41 2 4 0 0 0 1 0 33 5
2023/2024360 9 58 13 40 34 164 1 19 5 4 6 7
2024/20253.987 62 19 119 21 22 109 35 31 260 301 1.335 1.673
2025/20263.023 363 92 50 195 131 226 1.056 161 212 301 163 73
2026/202772 57 15 0 0 0 0 0 0 0 0 0 0
Totale 7.672